Skip to content

Lexion AP 50/30 Warmed Humidified Real Time CO2 Insufflation vs Airseal Recirculated CO2/Air Insufflation in Minimally Invasive Bariatric (Gastric Bypass) Surgery

Lexion AP 50/30 Warmed Humidified Real Time CO2 Insufflation vs Airseal Recirculated CO2/Air Insufflation in Minimally Invasive Bariatric (Gastric Bypass) Surgery: A Randomized Controlled Study of Clinical Evaluation

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05838300
Enrollment
54
Registered
2023-05-01
Start date
2023-05-19
Completion date
2025-12-30
Last updated
2025-06-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bariatric Surgery

Keywords

carbon dioxide, minimally invasive surgery

Brief summary

The purpose of this study is to To determine the effect of warm and humidified (WH) carbon dioxide (CO2) on post-operative pain/analgesia requirement in patients undergoing laparoscopic bariatric surgery.

Interventions

DEVICEWarm humidified CO2

Participants will receive warm (37°C) and humidified (95%) CO2.The humidification and warming device to be used is AlwaysPneumo® AP 50/30 InsuflowPort® (Lexion Medical, FDA approved) which is a specialized port that delivers warmed (95° F) and humidified (95% relative humidity) CO2, the source of which is a standard CO2 tank or wall source

DEVICEDry CO2

Participants will receive standard cold (19-21 °C) and non-humidified (0%) CO2 insufflation with Airseal Insufflator

Sponsors

The University of Texas Health Science Center, Houston
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* elective bariatric primary or revision procedures and hiatal hernia repair procedures for all indications.

Exclusion criteria

* emergency surgery, reoperation within 30 days * patients who are taking pain medications (narcotics) daily preoperatively for whatever reason * history of narcotics addiction * paraplegic and quadriplegic patients * dementia or altered mental status * patients on steroids * pregnant women * psychiatric patients * minors * unable to give informed consent

Design outcomes

Primary

MeasureTime frameDescription
Pain as assessed by the visual analog scale (VAS)First 24 hours after surgeryThis will be measured as a binary outcome variable (pain will be determined as VAS \>/= 4, and no pain will be VAS \< 4). This will be determined on post-operative day 1 as an average of the two pain scores.

Secondary

MeasureTime frameDescription
Temperature in the PACUFrom the time the patient enters PACU to the time patient leaves the PACU in minutesthe temperature of the patient in PACU measured each 30 minutes in PACU
Analgesic requirements in the Post Anesthesia Care Unit (PACU)From the time the patient enters the PACU to the time patient leaves the PACU in minutesthe amount, type and doses of drugs administered in the PACU to the patient
Volume of CO2 consumed during the procedurefrom the time the CO2 machine is turned on to the time the CO2 machine is turned off in minutesthe amount/volume of CO2 used during the procedure
Length of hospital staythe amount of hours the patient stays in the hospital (ie 24 hours)from admission to the hospital to discharge from the hospital in hours
Intraoperative temperature measured via bladder probe (average of the measurements on the anesthesia record)From the start surgery to the end of the surgery in minutesthe body temperature of the patient from the bladder
Incision lengthmeasurement in centimeters the patients incision lengths at the closing of the surgerythe length of the incisions on the patient abdomen
Intra-operative and total hospital costsfrom the admission to discharge of the patient in hoursthe cost for the intra-operative services and total hospital hospital costs
Total narcotic use intra-operatively (in morphine milliequivalents)volume of narcotics used from the beginning of surgery to end of surgery in milliequivalentsvolume of narcotics used during the operation
Postoperative Analgesia Requirement measured in morphine milliequivalentsany postoperative analgesia used after the surgery is completed to the discharge of the patient from the hospitalthe amount of analgesia used type, dose and amounts used post operatively
Duration of surgeryFrom start of the surgery to the end of the surgery in minutesfrom the start of the first incision of surgery to the closing of the last incision of surgery in minutes

Countries

United States

Contacts

Primary ContactErik B Wilson, MD,FACS
Erik.B.Wilson@uth.tmc.edu713-500-7277
Backup ContactAngielyn Rivera
Angielyn.R.Rivera@uth.tmc.edu713-416-1350

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026